Clinical Trial of CD40L-augmented TIL for Patients With Advanced Melanoma
Clinical trial NCT06961357 · RECRUITING
Trial details
- NCT number
- NCT06961357
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-03
- Primary completion
- 2029-05-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.